Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03290859 · ClinicalTrials.gov registry record
Race-Specific Propofol Titration to Effect for Procedural Sedation
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 2,780
- Enrollment target
NCT03290859: Completed study, sponsored by University of Florida.
NCT03290859 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 2,780 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03290859 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 2,780 participants
- Enrollment target
Study Summary
Prospectively evaluate newly established guidelines and make clinicians aware of inter-racial difference in propofol sensitivity.
Primary Outcome
Monitored using aggregate data for metrics of recovery times
Interventions
- PROCEDURE Titrate propofol monotherapy infusion to effect
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,780 participants |
| Start Date | 2018-01-05 |
| Est. Completion | 2019-02-05 |
What the finished NCT03290859 record still lists
NCT03290859 is an observational study that tracks outcomes without assigning an intervention. Its 2,780 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Titrate propofol monotherapy infusion to effect is the first listed.
NCT03290859 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03290859 about?
NCT03290859 is a clinical study titled "Race-Specific Propofol Titration to Effect for Procedural Sedation". Prospectively evaluate newly established guidelines and make clinicians aware of inter-racial difference in propofol sensitivity.
What is the current status of trial NCT03290859?
This trial is currently completed. The enrollment target is 2,780 participants. The study started on 2018-01-05. Estimated completion is 2019-02-05.
What interventions are being tested in trial NCT03290859?
The interventions under investigation include: Titrate propofol monotherapy infusion to effect (PROCEDURE).
Who is sponsoring clinical trial NCT03290859?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05443737 · 2,800 participants · Phase 3
Evaluation of a Telehealth Oncofertility Care Intervention in Adolescent and Young Adult Cancer Patients
- NCT05899439 · 2,800 participants
Immune Function and the Progression to T1D
- NCT06089109 · 2,800 participants · NA
Creating VIP Corps to Reduce Maternal Deaths
- NCT06345339 · 2,800 participants · Phase 2
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI